SCHEMBL6830891

SCHEMBL6830891

Cc1ccc(C(=O)Nc2ccc(OC(N)=O)cc2)c(Cl)n1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 4/20 0.44
▸ TYK2 P29597 2/20 0.41
▸ JAK2 O60674 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ NPC1 O15118 5/20 0.40
▸ RAB9A P51151 5/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ AHR P35869 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ POLB P06746 1/20 0.38
▸ TAS1R3 Q7RTX0 1/20 0.38
▸ TAS1R1 Q7RTX1 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7131171 0.82 EGFR (0.55) EGFRMEN1GAAKMT2ANPC1
SCHEMBL3223241 0.80 SMN1; SMN2 (0.54) EGFRKDM4EGAANPC1RAB9A
SCHEMBL6826031 0.76 SCN10A (0.47) KDM4EMEN1GAAKMT2ANPC1
SCHEMBL29377185 0.74 BRAF (0.41) EGFRMEN1KMT2AMAPT
SCHEMBL23779466 0.73 SMN1; SMN2 (0.47) EGFRMEN1KMT2ANPC1RAB9A
SCHEMBL27824692 0.73 PNLIP (0.54) KDM4EKMT2ASMN1; SMN2AHRMAPT
SCHEMBL6649755 0.73 PPARG (0.49) EGFRKDM4EMEN1GAAKMT2A
SCHEMBL11557801 0.72 EGFR (0.56) EGFRKDM4EMEN1GAAKMT2A
SCHEMBL27803848 0.72 RAB9A (0.56) KDM4EMEN1GAAKMT2ANPC1
SCHEMBL6644545 0.71 CHRNB2 (0.46) NPC1RAB9ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004039795-A2 AMIDE COMPOUNDS FOR THE TREATMENT OF HYPERLIPIDEMIA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-05-13 — — WO disclosed
Send feedback